APA (7th ed.) Citation

Uemura, H., Satoh, T., Tsumura, H., Arai, G., Imanaka, K., Shibayama, K., . . . Smith, M. (2020). Efficacy and safety of apalutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: A subgroup analysis of a randomized, double-blind, placebo-controlled, Phase-3 study. Elsevier.

Chicago Style (17th ed.) Citation

Uemura, Hiroji, et al. Efficacy and Safety of Apalutamide in Japanese Patients with Nonmetastatic Castration-resistant Prostate Cancer: A Subgroup Analysis of a Randomized, Double-blind, Placebo-controlled, Phase-3 Study. Elsevier, 2020.

MLA (9th ed.) Citation

Uemura, Hiroji, et al. Efficacy and Safety of Apalutamide in Japanese Patients with Nonmetastatic Castration-resistant Prostate Cancer: A Subgroup Analysis of a Randomized, Double-blind, Placebo-controlled, Phase-3 Study. Elsevier, 2020.